| Participants list |
Industries
Abbott Bioresearch Center, USA
Abbott Laboratories, USA
ActivX Biosciences, USA
ADV Bioscience LLC, USA
AstraZeneca, UK
Biogen Idec, Inc., USA
BioPerspectives, USA
Boehringer Ingelheim Pharma GmbH, Germany
Boryung Pharmaceutical Company, Korea
Bruker daltonik GmbH, Germany
Cangen Biotechnologies, USA
Cellzome AG, USA
Centocor R&D Inc., USA
CSIRO Molecular & Health Technologies, Australia
DSM Biologics Company BV, The Netherlands
Eprogen, Inc., USA
Eureka Therapeutics Inc., USA
F. Hoffmann-La Roche, Switzerland
Fluorotronics, Inc., USA
FOGALE Nanotech, France
GE Global Research Center, USA
Genetix, UK.
GenScript Corporation, USA
Genzyme, Switzerland
Hoffmann-LaRoche Inc., USA
HTL Biosolutions Inc., USA.
JENEIL BioProducts GmbH, Germany
Kyorin Pharmaceutical Co., LTD., USA
Lectus Therapeutics Ltd, UK
Life Technologies, USA
Medarex Inc., USA
Medicinal Chemistry, UCB, UK
MedImmune LLC, USA
Merck & Co., Inc., USA
Millipore Corporation, USA
Nerviano Medical Sciences, Italy
NeuroDrug Consulting, USA
Novartis, China
Novozymes A/S, Denmark
PamGene BV, The Netherlands
Pfizer Global Research and Development, USA
Pharmadiscover Inc., China
Prolexys Pharmaceuticals, USA
Rainbow Bioscience, LLC, USA
Sanofi Pasteur, France
Seattle Genetics, USA
Sigma-Aldrich Biotechnology, USA
Sundia MediTech Company, Ltd., China
SuppreMol GmbH, Germany
Trellis Bioscience, USA
Vitae Pharmaceuticals Inc., USA
Vybion,Inc., USA
Wyeth Research, USA
Academia
Advanced Science Institute, Japan
Agricultural Research Council( CRA ), Italy
AIIMS, India
AIST Tokyo Waterfront, Japan
Biotechnology Research Institute, Canada
Boston University School of Medicine, USA
Brussels Center for Redox Biology, Belgium
Butler University, USA
Cardiff University, UK
Case Western Reserve University School of Medicine, USA
Cell Surface Signalling Laboratory, UK
Centinela Freeman Memorial Hospital, USA
Central Division of Analytical Chemistry, Germany
Chemistry RAMS, Russia
Children's Hospital of Orange County, USA
Clinical Proteomics Center, Taiwan
Consortium for Genomic Technologies, Italy
Cornell University, USA
Craig Venter Institute, USA
Dalhousie University, Canada
Department of Chemistry, University of Ioannina, Greece
Eindhoven University of Technology, The Netherlands
Erasmus Medical Center, Netherlands
ETH Zurich, Switzerland
Federal University of Rio de Janeiro, Brazil
Florida State University, USA
Fox Chase Cancer Center, USA
Fred Hutchinson Cancer Research Center, USA
Georgia Institute of Technology, USA
Goethe University, Germany
Hannam University, Korea
Harvard University, USA
HELIOS Klinikum Berlin-Buch and Experimental and Clinical Research Center, Germany
Hiroshima University, Japan
Hungarian Academy of Sciences, Hungary
Ibaraki University, Japan
Idaho State University, USA
Indiana University, USA
Institut de Pharmacologie Moléculaire et Cellulaire, France
Institut Pasteur de Lille, France
Institute for Biology and Chemistry of Proteins, France
Institute of Mechanics Bulgarian Academy of Sciences, Bulgaria
Institute of Microbial Technology, India
Institute of Molecular Biology and Biological Physics, USA
Iwate medical University, Japan
Jamia Millia Islamia(Central University), India
Johns Hopkins Hospital, USA
Johns Hopkins University School of Medicine, USA
Joseph Fourrier University, France
Karolinska University Hospital, Sweden
Katholieke Universiteit, Belgium
King Saud University, Kingdom of Saudi Arabia
Kyoto University, Japan
Kyungpook National University, Korea
Liver Research Center & Department of Hepato-Gastroenterology, Taiwan
London Research Institute, UK
M. D. Anderson Cancer Center, USA
Masaryk University, Czech Republic
Max-Planck Institute of Molecular Physiology, Germany
McGill University, Canada
McMaster University, Canada
Middle East Technical University, Turkey
Midwestern University, USA
MIT, USA
Moffitt Cancer Center & Research Institute, USA
Monash University, Australia
Mount Sinai School of Medicine, USA
Nara Institute of Science and Technology, Japan
Nara Women's University, Japan
National Institutes of Health, USA
National University of Singapore, Singapore
Newcastle University, UK
Northwest A & F University, China
Osaka University, Japan
oungnam University, Korea
Padmashree Dr. D.Y. Patil University, India
Princeton University, USA
Proteomics International, Australia
PSG College of Pharmacy, India
Rensselaer Polyechnic Institute, USA
Rice University, USA
Second Affiliated Hospital of Soochow University, China
Sejong University, Korea
Seoul National University, Korea
St. Jude Children's Research Hospital, USA
Stanford University, USA
State University of New York, USA
Stony Brook University, USA
Stowers Institute for Medical Research, USA
The Chinese University of Hong Kong, China
The Hebrew University of Jerusalem, Israel
The Italian Institute of Technology, Italy
The Ohio State University, USA
The University of Adelaide, Australia
The University of Iowa, USA
The University of Kansas, USA
The University of Melbourne, Australia
The University of North Carolina at Chapel Hill, USA
The University of Tokyo, Japan
The University of Texas M.D. Anderson Cancer Center, USA
Tohoku University, Japan
United States Department of Agriculture, USA
Universidad Nacional Autnoma de Mxico, Mexico City
Universita degli studi di pavia, Italy
Université de Montréal, Canada
Universite de Sherbrooke, Canada
Université Paris, France
Université Rennes, France
University College London, UK
University Graz, Austria
University in Innsbruck, Austria
University of Bristol, UK
University of California, USA
University of Chicago, USA
University of Chicago, USA
University of Cincinnati, USA
University of Erlangen-Nuremberg, Germany
University of Florida College of Medicine, USA
University of Haifa, Israel
University of Heidelberg, Germany
University of Hong Kong, China
University of Illinois, USA
University of Ioannina, Greece
University of Leeds, UK
University of Leeds, UK
University of Liverpool Cancer Research Centre, UK
University of Malaya centre for Proteomics research, Malaysia
University of Medical Sciences, Iran
University of Melbourne, Australia
University of Michigan, USA
University of Minnesota, USA
University of Mississippi Medical Center, USA
University of Miyazaki, Japan
University of Montreal, Canada
University of Munich, Germany
University of North Carolina at Chapel Hill, USA
University of North Carolina, USA
University of Oslo, Norway
University of Otago, Christchurch Cardioendocrine Research Group, New Zealand
University of Oulu, Finland
University of Oulu, Finland
University of Pennsylvania, USA
University of Pittsburgh Drug Discovery Institute, USA
University of Pittsburgh School of Medicine, USA
University of Pittsburgh, USA
University of Portsmouth, UK
University of Rochester School of Medicine and Dentistry, USA
University of Science and Technology of Lille, France
University of South Australia, Australia
University of Stuttgart, Germany
University of Tartu, Estonia
University of Texas Medical Branch, USA
University of Texas, USA
University of Tokyo, Japan
University of Toronto, Canada
University of Virginia, USA
University of Washington, USA
University of Waterloo, Canada
University of Western Ontario, Canada
University of Western Sydney, Australia
University of Zagreb, Croatia
University of Zürich, Switzerland
University of California, USA
University of Houston, USA
University of Illinois College of Medicine, USA
University of Massachusetts Medical School, USA
University of Pittsburgh School of Medicine, USA
Uppsala University, Sweden
Vanderbilt University Medical Center, USA
Vanderbilt University, USA
Walter and Eliza Hall Institute of Medical Research, Australia
Weill Medical College of Cornell University, USA
Yale University School of Medicine, USA
Yale University, USA
Yokohama National University, Japan
Yonsei University, Korea
Youngnam University, Korea
|
|
 |
 |
|
|
|
|
|
|
| Past Event Report |
|
PepCon-2008
Hosted by China Medicinal Biotech Association and organized by BIT Life Sciences, Inc., the 1st Annual Protein and Peptide Conference (PepCon-2008), held in Shenzhen Convention & Exhibition Center from April 22 to 24, 2008, achieved a consummation. The theme of this conference is "From Concept to Market". Many honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Harold A. Scheraga, eminent leader in protein folding, Dr. Marc Wilkins, who has defined the concept of the proteome and coined the term, Dr. David K. Robinson, Vice President, Bioprocess R&D, Merck Research Laboratories, Merck & Co., Inc., USA and Dr. Thomas Li, Head of Asia Pacific Technology Management, Roche Diagnostics Asia Pacific Pte. Ltd., USA. Nearly 500 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises from 31 countries attended the ceremony.
There were altogether 24 sessions following the ceremony, including Proteomics, Human Proteome Project, Bioinformatics, Protein Structure and Interaction, Biomarkers, Protein and Peptide Drug Discovery, Vaccine and Antibody, Investing and Financing, Outsourcing and Business Cooperation, etc.
Synchronously, New Product & Technology Exhibition attracted many instrument companies, peptide synthesis companies, outsourcing companies and database software companies internationally.
This annual conference, on one hand, provided a splendid platform for domestic researchers to communicate with international experts, offered excellent opportunities for domestic governors, enterprises, and institutes to seek cooperation, and on the other hand, promoted international exchanges and enhanced domestic scientific development in protein and peptide. Meanwhile, it pushed forward the development of relevant scientific fields worldwide and made an important contribution to human proteome project.
Website: http://www.bitlifesciences.com/pepcon2008
Overall, this conference bears the following characteristics:
First, PepCon-2008 focused on protein and peptide research areas which led its way to be a professional conference covering most popular topics.
Second, PepCon-2008 attracted international experts and professors from 31 countries to attend actively and contribute greatly which made it an impressive and influential conference.
Third, all presented at the conference are distinctive representatives and experts in protein and peptide from both academia and industry.
Fourth, PepCon-2008 attracted great interest of corporations, both domestic and internal, to participate in the conference actively.
|
 |
 |
 |
 |
|
Opening Ceremony of Pepcon 2008 was held on April 22, 2008 in Shenzhen Convention & Exhibition Center. |
|
Dr. Harold A. Scheraga, Todd Professor of Cornell University, USA gave a presentation in keynote forum |
|
Welcome banquet and celebrating 60 years of professor Harold A. Scheraga's science (1948-2008) |
|
Dr. Marc Wilkins, Professor, University of New South Wales, Australia gave a presentation in keynote forum |
|
 |
 |
 |
 |
Dr. David K. Robinson, Vice President, Bioprocess R&D, Merck Research Laboratories, Merck & Co., Inc., USA gave a presentation in keynote forum |
|
More than 500 people participated opening ceremony and other program of PepCon 2008 |
|
Dr. Thomas M. Li, Senior Director, Technology Mgmt., Chief Technology Officer, Roche Diagnostics, USA delivered the opening speech |
|
Dionex Corporation as the representative of more than 20 world famous companies attended the exhibition |
|
|
------------------------------------------------------------------------------------------------------------------------------------------------ |
PepCon-2009
|
BIT Life Sciences' 2nd annual Protein and Peptide congress (PepCon-2009), held in COEX Convention & Exhibition Center, Seoul, South Korea during April 2-4, 2009, gained the overwhelming success. The theme of this conference is "Life, Knowledge & Bio-Economy". Many honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Kyung-Soo Hahm, Professor, Cellular and Molecular Medicine, College of Medicine, Research Center for Proteineous Materials, Chosun University; President of the Korean Peptide Protein Society, South Korea; Dr. Young-Ki Paik, President, HUPO and AOHUPO, Director of Yonsei Proteome Research Center/Biomedical Proteome Research Center, Yonsei University, Seoul, South Korea; Dr. Gregg B. Fields, Robert A. Welch Foundation Distinguished Professor of Chemistry, Department of Biochemistry, The University of Texas Health Science Center; President Elect of American Peptide Society (APS), USA; Dr. Han-Oh Park, CEO & President, Bioneer Corp., South Korea; Dr. Thomas Seewoester, Director, Process Development, Amgen Inc., USA. More than 200 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference. |
 |
There were altogether 5 tracks including more than 20 sessions following the Opening Ceremony & Plenary Lectures, including Human Proteome Technologies, Protein Sciences and Technology, Protein Therapeutics Discovery and Development, Bioengineering or Bioprocessing: Protein Downstream Technologies, Peptide Structure and Functions and Therapeutic Designs, etc. Meanwhile, the grand congress was greatly supported by Bioneer Corp., South Korea, also attracted many exhibitors such as Bachem AG, Switzerland; GENEART AG, Germany; Beijing Scilight Biotechnology, China; vivoPharm Pty Ltd, Australia; Young-IN Scientific.co., Ltd., Korea & Young In Frontier, Korea; Kyongshin Scientific Co., Ltd., Korea, ect.
This annual conference, brought together more than 200 specialists from 26 countries and areas, was devoted to the leading issues and hottest topics and
provide d up-to-date information to all over the world. On the other hand, the meeting provided a splendid informative platform for domestic researchers to communicate with international experts and pushed forward the Protein and Peptide development. |
 |
According to the investigation after the conference, over 70% participants expressed that they would like to attend PepCon-2010. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing PepCon-2010, Beijing, China which would be better and more successful than PepCon-2009. |
| |
|
|
|
|
|
Dr. Young-Ki Paik, President, HUPO and AOHUPO, Director of Yonsei Proteome Research Center/Biomedical Proteome Research Center, Yonsei University, Seoul, South Korea
|
Dr. Thomas Seewoester,
Director, Process Development, Amgen Inc., USA |
Dr. Kyung-Soo Hahm,
Professor, Cellular and Molecular Medicine, College of Medicine, Research Center for Proteineous Materials, Chosun University; President of the Korean Peptide Protein Society, South Korea |
Dr. Han-Oh Park,
CEO & President, Bioneer Corp., South Korea |
Dr. Gregg B. Fields, Robert A. Welch Foundation Distinguished Professor of Chemistry, Department of Biochemistry, The University of Texas Health Science Center; President Elect of American Peptide Society (APS), USA |
|
| |
Website: http://www.bitlifesciences.com/pepcon2009 |
|